Adrian Chrastina

Proteogenomics Research Instit/Sys/ Med

$3,048,929

Attributed

$3,048,929

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $716.9K · FY2019–23

$1M$750K$500K$250K$0

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$3,048,929 · 2

By mechanism

R01$2,099,012 · 1

P01$949,917 · 1

Top collaborators

No co-investigators on record.

Most similar at Proteogenomics Research Instit/Sys/ Med

Same institution · by research overlap

Jacqueline Elizabeth Testa$2,150,838
Phil Oh$328,394

Others in their field

Other Emerging Leaders on “Novel Therapeutics”

Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220

Research focus

Novel TherapeuticsIntravital MicroscopySolid NeoplasmTissuesNeoplasm MetastasisExperimental StudyMalignant NeoplasmsPharmaceutical PreparationsTumorAntibodiesCaveolaeBaseBreast Cancer TherapyBreast Cancer ModelAntibody-Drug ConjugatesBlood VesselsClinical ApplicationBlood CirculationDrug Delivery SystemsBloodChemotherapyAnnexin A1ChemistryDiagnosis